SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,770.00    75.00 (1.12%)
Bid:
6,765.00
Ask:
6,775.00
Spread: 10.00 (0.148%)
Market Cap: £5.00b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Acquisition

3 Apr 2017 07:30

RNS Number : 2765B
Spirax-Sarco Engineering PLC
03 April 2017
 

 

3rd April 2017

Acquisition of Gestra for €186 million (£160 million)

Spirax-Sarco Engineering plc (Spirax Sarco), which specialises in the control and efficient use of steam, and in peristaltic pumping and associated fluid path technologies, announces that it has signed a conditional sale and purchase agreement to acquire Gestra AG and associated businesses (Gestra) from Flowserve Corporation for a cash-free, debt-free consideration of €186 million (£160 million). 

Gestra, which has its headquarters in Bremen, Germany, is a technology leader in advanced industrial boiler control systems and specialises in the design and production of valves and control systems for steam and fluid process control.

In 2016, Gestra recorded revenues of €92.5 million (£79.7 million), EBITDA of €16.6 million (£14.3 million) and EBIT of €15.2 million (£13.1 million). Approximately 80% of the company's revenues are in Europe with the balance spread roughly evenly between the Americas and Asia Pacific. 

At 31st December 2016, Gestra's gross assets were €66.8 million (£57.6 million). 

Gestra is highly complementary to the Spirax Sarco Steam Specialties business and will enhance and accelerate the implementation of Spirax Sarco's strategy for growth, as a result of its well-developed capabilities in a wide range of industries and applications.

Due to its strong brand, Gestra will be operated alongside the Spirax Sarco Steam Specialties business, targeting global growth in its key market sectors through the co-ordinated application of the knowledge and strengths of both businesses. Spirax Sarco will invest in Gestra's product and market development to extend its world-leading customer value proposition to an enlarged addressable market. 

The purchase consideration will be financed from a combination of existing cash resources and debt facilities. The acquisition will be accretive to Group earnings in 2017 but is expected to have a slightly dilutionary impact on the Group profit margin in this year.

Completion is subject to certain customary conditions, including regulatory approval of the transaction by the merger control authority in Germany. These conditions are expected to be satisfied during the current quarter. 

Nicholas Anderson, Chief Executive of Spirax-Sarco Engineering plc, said;

"We are delighted to be bringing Gestra, its management and employees into the Spirax Sarco family. Our businesses are highly complementary; Gestra will enhance the market and product offering of Spirax Sarco and will benefit from our global footprint and broader product range. We believe that this combination will deliver enhanced value to both customers and shareholders".

There will be a hosted conference call, including Q&A, for investors and analysts at 9.30am UK time today. Dial-in numbers are UK Toll Free 0808 109 0700 and for Standard International Access +44 20 3003 2666. Please use the password 'Spirax-Sarco'.

 

 

 

Enquiries:

Nicholas Anderson, Chief Executive

Kevin Boyd, Group Finance Director

Tel: 01242 535234

 

About Spirax Sarco

Spirax-Sarco Engineering plc comprises two niche businesses, Spirax Sarco for steam specialties and Watson-Marlow Fluid Technology Group for peristaltic pumps and associated fluid path technologies. The Steam Specialties business provides a broad range of fluid control products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. The Company helps its end users to improve production efficiency, reduce energy costs, water usage and emissions, improve product quality and enhance the safety of their operations. Watson-Marlow Fluid Technology Group offers the ideal solution for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance free pumps and associated technologies. The Group is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs over 5,300 people, of whom nearly 1,400 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX).

 Further information can be found at www.spiraxsarcoengineering.com

 

RNS filter: Inside information prior to release

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAELAEENXEAF
Date   Source Headline
21st Nov 20173:08 pmRNSDirector/PDMR Shareholding
21st Nov 20177:00 amRNSTrading Statement
14th Nov 201710:39 amRNSDirector/PDMR Shareholding
16th Oct 20175:35 pmRNSDirector/PDMR Shareholding
29th Sep 20173:36 pmRNSHolding(s) in Company
9th Aug 20177:00 amRNSHalf-year Report
4th Jul 20177:00 amRNSCompletion of Acquisition
23rd Jun 20179:11 amRNSTotal Voting Rights
20th Jun 20173:59 pmRNSHolding(s) in Company
12th Jun 20172:20 pmRNSDirector/PDMR Shareholding
5th Jun 20179:08 amRNSDirector/PDMR Shareholding
26th May 20177:00 amRNSAcquisition of Chromalox for US$415 million
9th May 20174:30 pmRNSResult of AGM
9th May 20177:00 amRNSTrading Statement
4th May 20174:30 pmRNSHolding(s) in Company
3rd May 20177:00 amRNSCompletion of Acquisition
26th Apr 20178:42 amRNSHolding(s) in Company
25th Apr 20179:10 amRNSHolding(s) in Company
19th Apr 20173:55 pmRNSHolding(s) in Company
18th Apr 20173:58 pmRNSHolding(s) in Company
3rd Apr 20177:30 amRNSAcquisition
24th Mar 20174:44 pmRNSTotal Voting Rights
23rd Mar 20171:45 pmRNSDirector/PDMR Shareholding
17th Mar 20174:04 pmRNSDirector/PDMR Shareholding
9th Mar 20177:00 amRNSFinal Results
30th Nov 20167:00 amRNSAcquisition
22nd Nov 20167:00 amRNSTrading Statement
17th Nov 20164:23 pmRNSDirector/PDMR Shareholding
14th Nov 20168:30 amRNSDr Krishnamurthy Rajagopal
10th Nov 201611:40 amRNSListing Application
8th Nov 201611:57 amRNSChange of Director Details
4th Nov 20164:27 pmRNSTotal Voting Rights
28th Oct 20167:00 amRNSBoard Succession Changes
17th Oct 20162:49 pmRNSAdditional Listing
14th Oct 20165:03 pmRNSDirector/PDMR Shareholding
14th Oct 20163:20 pmRNSTotal Voting Rights
14th Oct 20163:17 pmRNSBlock listing Interim Review
6th Oct 201611:48 amRNSNotification of Release Date - Trading Statement
8th Sep 201612:44 pmRNSTotal Voting Rights
18th Aug 20168:30 amRNSBoard Appointment
12th Aug 20163:51 pmRNSDirector/PDMR Shareholding
9th Aug 20167:05 amRNSSpirax Sarco acquires assets of Hiter for £3.9 m
9th Aug 20167:00 amRNS2016 Half Year Results
5th Aug 20162:56 pmRNSTotal Voting Rights
1st Jul 201611:43 amRNSTotal Voting Rights
29th Jun 20169:29 amRNSNotice of Results
21st Jun 20165:40 pmRNSDirector/PDMR Shareholding
10th Jun 20162:59 pmRNSHolding(s) in Company
2nd Jun 20164:20 pmRNSAdditional Listing
2nd Jun 20163:28 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.